M&A Deal Summary

Martindale Pharmaceuticals Acquires Viridian Pharma

On July 11, 2016, Martindale Pharmaceuticals acquired medical products company Viridian Pharma

Acquisition Highlights
  • This is Martindale Pharmaceuticals’ 1st transaction in the Medical Products sector.
  • This is Martindale Pharmaceuticals’ 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2016-07-11
Target Viridian Pharma
Sector Medical Products
Buyer(s) Martindale Pharmaceuticals
Deal Type Add-on Acquisition

Target

Viridian Pharma

Hendrew Lane, United Kingdom
Viridian Pharma Ltd. is a developer and supplier of niche pharmaceutical products.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Martindale Pharmaceuticals

Brentwood, United Kingdom

Category Company
Founded 1972
Sector Life Science
Revenue 65M EUR (2010)
DESCRIPTION

Martindale Pharmaceuticals Ltd. is a niche manufacturer and supplier of specialty pharmaceutical products and services, including Unlicensed medicines (‘Specials’), injectables, pre-filled syringes and oral solutions. Martindale has a diverse portfolio of over 200 licensed compounds and a proprietary database of 30,000 formulations for Specials. Martindale’s in-house expertise covers the full product lifecycle from formulation, to product development, registration and licensing, manufacturing and full quality monitoring and testing.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2016 M&A 1 of 1